Skip to main content
. 2021 Dec;10(12):3181–3187. doi: 10.21037/gs-21-643

Table 4. Complications.

Complications Control (N=142), n (%) Trial (N=164), n (%) P
Seroma 0.965
   No 127 (89.4) 148 (90.2)
   Yes 15 (10.6) 16 (9.8)
Hematoma 0.999
   No 141 (99.3) 162 (98.8)
   Yes 1 (0.7) 2 (1.2)
Cellulitis 0.999
   No 142 (100.0) 163 (99.4)
   Yes 0 (0.0) 1 (0.6)